A Review Of nembutal medication information
A Review Of nembutal medication information
Blog Article
pentobarbital will reduce the extent or influence of theophylline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will lower the extent or effect of atazanavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Mysterious.
pentobarbital will minimize the level or effect of irinotecan liposomal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will lessen the extent or influence of eucalyptus by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Not known.
pentobarbital decreases amounts of panobinostat by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Solid CYP3A4 inducers can cut down panobinostat levels by ~70% and result in remedy failure.
Phenytoin and barbiturate blood concentrations really should be monitored a lot more usually if offered concurrently; impact of barbiturates on phenytoin metabolism documented being variable; sodium valproate and valproic acid surface to lower barbiturate metabolism; keep track of barbiturate blood concentrations and make appropriate dosage adjustments as essential
pentobarbital will lower the extent or result of bazedoxifene/conjugated estrogens by influencing hepatic/intestinal website enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will lessen the level or outcome of piroxicam by affecting hepatic enzyme CYP2C9/10 metabolism. Insignificant/Importance Unidentified.
pentobarbital will reduce the extent or impact of propafenone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unidentified.
pentobarbital will minimize the level or influence of etoposide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
pentobarbital will minimize the level or influence of bosentan by affecting hepatic enzyme CYP2C9/10 metabolism. Minimal/Importance Unidentified.
pentobarbital will reduce the extent or result of fruquintinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. If coadministration with reasonable CYP3A4 inducers is unavoidable, carry on to administer fruquintinib at recommended dosage.
pentobarbital will decrease the extent or result of apremilast by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Coadministration with solid CYP inducers ends in a big reduce of systemic publicity of apremilast, which can end in lack of efficacy
pentobarbital will minimize the extent or impact of stiripentol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. If struggling to prevent coadministration of stiripentol with sturdy CYP3A4 inducers, boost stiripentol dose.